Analystreport

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report